<DOC>
	<DOCNO>NCT00210704</DOCNO>
	<brief_summary>The primary purpose study demonstrate dapoxetine prolong intravaginal ejaculatory latency time ( IELT ) compare placebo men premature ejaculation ( PE ) .</brief_summary>
	<brief_title>A Study Effectiveness Safety Dapoxetine Treatment Men With Premature Ejaculation</brief_title>
	<detailed_description>Premature ejaculation ( PE ) form male sexual dysfunction . An objective measurement PE clinical study intravaginal ejaculatory latency time ( IELT ) . This multicenter , placebo-controlled , double-blind , randomize , parallel-group study men PE . The study consist 2 phase : pre-randomization phase ( screen visit 4-week baseline period ) ; 12-week double-blind treatment phase patient receive dapoxetine placebo use `` as-needed '' basis , post-study telephone contact approximately 2 week end treatment . The total duration study approximately 18 week . Assessments effectiveness include average intravaginal ejaculatory latency time ( measure stopwatch ) sexual intercourse , treatment period ; control ejaculation , satisfaction sexual intercourse , severity symptom , base question ask monthly interval treatment phase . Safety assessment include incidence , severity , type adverse event study , well laboratory test questionnaire monitor sexual function specify time study . The study hypothesis treatment 12 week dapoxetine prolongs intravaginal ejaculatory latency time , compare placebo , men PE . Oral tablet dapoxetine ( 30 milligram [ mg ] 60mg ) placebo take need 12 week treatment . No 1 dose within 24-hour period .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Premature Ejaculation</mesh_term>
	<criteria>Male citizen Asian country Australia encourage enroll study patient stable , monogamous sexual relationship woman least 6 month plan maintain relationship duration study diagnosis premature ejaculation ( PE ) accord criterion Diagnostic Statistical Manual Mental Disorders ( DSMIVTR ) least 6 month study initiation history intravaginal ejaculatory latency time ( IELT ) &lt; 2 minute least 3 4 event patient 's partner must negative urine pregnancy test time screen Not take dapoxetine participate another study investigate pharmacologic treatment PE within last 3 month history medical event associate development PE take another investigational drug within 1 month , use experimental medical device within 6 month study initiation positive diagnosis depressive anxiety disorder , manic episode , panic disorder , obsessivecompulsive disorder , posttraumatic stress disorder , alcohol abuse dependence , schizophrenia , psychotic disorder know allergy hypersensitivity selective serotonin reuptake inhibitor ( SSRIs ) serotonin norepinephrine reuptake inhibitor ( SNRIs )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>dapoxetine</keyword>
	<keyword>premature ejaculation</keyword>
	<keyword>ejaculation</keyword>
	<keyword>sexual dysfunction</keyword>
	<keyword>orgasmic disorder</keyword>
	<keyword>sexual intercourse</keyword>
</DOC>